Abstract
When examining radiographs of patients with Paget’s disease of bone (PD), we often observed calcification of the aorta and iliac or femoral arteries. The processes of extraosseous calcification or mineralization are very close to the mechanisms regulating mineralization of bone tissue. The aim of our study was to quantify the number, extent (length and thickness), and type (arteriosclerotic or medial arterial calcification) of vascular calcification in patients with Paget’s disease and to compare them with those of controls, in order to discover whether PD is accompanied by increased calcification. Vascular calcification was quantified on the aorta, the iliac arteries, and their branches, the femoral, gluteal, and pelvic arteries of 42 patients with Paget’s disease and 36 control subjects. Of the PD subjects, 52.4% had arteriosclerotic calcification versus 30.6% of controls (P = 0.05), and 38.6% of PD patients had medial arterial calcification versus 11.1% of controls (P = 0.05). The mean length of calcification was greater in PD patients: 1.93 ± 2.85 cm versus 0.84 ± 1.69 cm in controls (P = 0.04). The thickness of calcification was also greater in PD patients: 1.24 ± 1.30 mm versus 0.56 ± 0.94 mm (P = 0.01). Patients with Paget’s disease more frequently had medial arterial or arteriosclerotic calcification than controls. These calcifications were longer and thicker. Our clinical study therefore confirms that abnormal vessel wall calcification and bone remodeling in Paget’s disease are probably linked, although the mechanism of this relation is as yet unexplained.
Similar content being viewed by others
References
Schiano A, De Baillou H, Desnuelle C, Schiro S, Acquaviva PC, Serratrice G (1988) Les calcifications artérielles dans la maladie de Paget. Rev Rhum 55:541–544
May V, Meignan S (1975) Les manifestations cardio-vasculaires dela maladie de Paget. Rev Rhum 42:555–561
Acar J, Delbarre F, Waynberger M (1968) The cardiovascular complications of Paget’s disease of bone. Arch Mal Cæur Vaiss 61:849–868
Wallin R, Wajih N, Greenwood GT, Sane DC (2001) Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev 21(4):274–301
Anderson HC (1983) Calcific diseases: a concept. Arch Pathol Lab Med 107:341–348
Elkeles A (1957) A comparative radiological study of calcified atheroma in males and females over 50 years of age. Lancet 273(6998):714–715
Rénier JC, Cronier P, Audran M (1995) A new anatomic index based on current knowledge for calculating the cumulative percentage of pagetic bone per subject and other parameters. Rev Rhum Engl Ed 62:373–377
Strickberger SA, Schulman SP, Hutchins GM (1987) Association of Paget’s disease of bone with calcific aortic valve disease. Am J Med 82(5):953–956
Tintut Y, Demer LL (2001) Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 12(5):555–560
Bostrom K, Demer LL (2000) Regulatory mechanisms in vascular calcification. Crit Rev Eukaryot Gene Expr 10(12):151–158
Bostrom K (2001) Insight into the mechanism of vascular calcification. Am J Cardiol 88(2A):20E–22E
Proudfoot D, Skepper JN, Hegyi L, Farzaneh-Far A, Shanahan CM, Weissberg PL (2001) The role of apoptosis in the initiation of vascular calcification. Z Kardiol 90(Suppl 3):43–46
Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL (1997) Lipid oxidation produits have opposite effects on calcifying vascular cell and bone cell differentiation. Arterioscler Thromb Vasc Biol 17:680–687
Fitzpatrick LA, Sieck GC, Miller VM (1998) Gender-related differences in atherosclerosis: differential effects of estrogens on proliferation of vascular smooth muscle cells. Circulation 98:183
Fitzpatrick LA (1996) Gender-related differences in the development of atherosclerosis: studies at the cellular level. Clin Exp Pharmacol Physiol 23:267–269
Moraghan T, Antoniucci DM, Grenert JP, Sieck GC, Johnson C, Miller VM, Fitzpatrick LA (1996) Differential response in cell proliferation to beta estradiol in coronary arterial vascular smooth muscle cells obtained from mature female versus male animals. Endocrinology 137:5174–5177
Jono S, Nishizawa Y, Shioi A, Morii H (1997) Parathyroid hormone-related peptide as a local regulator of vascular calcification. Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:1135–1142
Jono S, Nishizawa Y, Shioi A, Morii H (1998) 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related-peptide. Circulation 98:1302–1306
Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755–1760
Arad Y, Spadaro LA, Roth M, Scordo J, Goodman K, Sherman S, Lerner G, Newstein D, Guerci AD (1998) Serum concentration of calcium, 1.25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study. Coron Artery Dis 9:513–518
Reddy SV, Menaa C, Singer FR, Cundy T, Cornish J, Whyte MP, Roodman GD (1999) Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget’s disease of bone. Exp Hematol 27(10):1528–1532
Mills BG, Frausto A (1997) Cytokines expressed in multinucleated cells: Paget’s disease and giant cell tumors versus normal bone. Calcif Tissue Int 61(1):16–21
Daroszewska A, Hocking LJ, Mcguigan FEA, Langdahl B, Stone MD, Cundy T, Nicholson GC, Fraser WD, Ralston SH (2004) Susceptibility to Paget’s Disease of bone is influenced by a common polymorphic variant of osteoprotegerin. J Bone Miner Res 19:1506–1512
Takata S, Yasui N, Nakatsuka K, Ralston SH (2004) Evolution of understanding of genetics of Paget’s disease of bone and related diseases. J Bone Miner Metab 22:519–523
Cavey JR, Ralston SH, Hocking LJ, Sheppard PW, Ciani B, Searle MS, Layfield R (2005) Loss of ubiquitin-binding associated with Paget’s disease of bone p62 (SQSTM1) mutations. J Bone Miner Res 20:619–626
Sattler AM, Schoppet M, Schaefer JR, Hofbauer LC (2004) Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease. Calcif Tissue Int 74(1):103–106
Price PA, Faus SA, Williamson MK (2001) Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 21(5):817–824
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Laroche, M., Delmotte, A. Increased Arterial Calcification in Paget’s Disease of Bone. Calcif Tissue Int 77, 129–133 (2005). https://doi.org/10.1007/s00223-005-0250-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-005-0250-1